Bactigud announced its first MDR (Medical Device Regulations 20/745) product approval following a comprehensisive authorization process. The MDR approval relates to the latex BIP Foley Catheter which is an indwelling urinary catheter with Bactiguard's unique infection prevention technology. Bactiguard's patented technology is based on a thin noble metal alloy coating attached to the catheter surface.

When in contact with fluids, the metals create a galvanic effect which reduces microbial adhesion where fewer bacteria adhere to the catheter surface. one out of ten patients worldwide are affected by healthcare associated infections (HAI) and catheter-associated urinary tract infections (CAUTI) stand for a considerable part. Urinary catheters with Bactiguard's technology reduce the risk of CAUTI significantly.

Patient safety always comes first for Bactiguard, and stricter regulations are an advantage to us. Products scrutinized in the MDR -process are audited through higher standards of quality and safety. The BIP Foley catheter made it through this thorough process and will not only improve patient safety by reducing the risk of HAI but also by reducing the use of antibiotics.